Literature DB >> 5312248

The prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong Kong influenza in Leningrad in 1969.

A A Smorodintsev, G I Karpuhin, D M Zlydnikov, A M Malyseva, E G Svecova, S A Burov, L M Hramcova, J A Romanov, L J Taros, J G Ivannikov, S D Novoselov.   

Abstract

The effectiveness of amantadine hydrochloride as a prophylactic against influenza was studied during an epidemic caused by viruses related to influenza A2/Hong Kong/1968 variants in Leningrad, USSR, early in 1969. In all, 8169 subjects, assigned to amantadine-dosed, placebo-dosed, internal control and external control groups, were assessed. The index of effectiveness of the prophylactic medication, based on clinical diagnosis, in subjects who took amantadine regularly was 1.95. When the clinical diagnoses were confirmed serologically the index of effectiveness for the amantadine compared with the placebo group increased to 2.7. A comparison of the medicated group with the non-medicated, non-isolated internal control group showed an index of effectiveness of 5.34. A daily dose of 100 mg of amantadine was associated with an increase of 1.14% in complaints of sleep disturbances but these had no effect on the working capacity of subjects.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5312248      PMCID: PMC2427564     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  SEROLOGICAL EVIDENCE FOR PREVENTION OF INFLUENZAL INFECTION IN VOLUNTEERS BY AN ANTI-INFLUENZAL DRUG ADAMANTANAMINE HYDROCHLORIDE.

Authors:  G G JACKSON; R L MULDOON; L W AKERS
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

2.  ANTIVIRAL ACTIVITY OF AMANTADINE HYDROCHLORIDE IN TISSUE CULTURE AND IN OVO.

Authors:  E M NEUMAYER; R F HAFF; C E HOFFMAN
Journal:  Proc Soc Exp Biol Med       Date:  1965-06

3.  Inhibition of influenza viruses in vitro and in vivo by 1-adamantanamine hydrochloride.

Authors:  G C Schild; R N Sutton
Journal:  Br J Exp Pathol       Date:  1965-06

4.  Studies on the antiviral activity of amantadine hydrochloride.

Authors:  K W Cochran; H F Maassab; A Tsunoda; B S Berlin
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

5.  Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain.

Authors:  Y Togo; R B Hornick; A T Dawkins
Journal:  JAMA       Date:  1968-03-25       Impact factor: 56.272

6.  Studies on the antiviral activity of 1-adamantanamine.

Authors:  D A Tyrrell; M L Bynoe; B Hoorn
Journal:  Br J Exp Pathol       Date:  1965-08

7.  Influenza virus growth and antibody response in amantadine-treated mice.

Authors:  W L Davies; R R Grunert; C E Hoffmann
Journal:  J Immunol       Date:  1965-12       Impact factor: 5.422

8.  The suppression of A2 influenza in children by the chemoprophylactic use of Amantadine.

Authors:  J J Quilligan; M Hirayama; H D Baernstein
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406

9.  THE IN VIVO ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). I. PROPHYLACTIC AND THERAPEUTIC ACTIVITY AGAINST INFLUENZA VIRUSES.

Authors:  R R GRUNERT; J W MCGAHEN; W L DAVIES
Journal:  Virology       Date:  1965-06       Impact factor: 3.616

10.  ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

Authors:  W L DAVIES; R R GRUNERT; R F HAFF; J W MCGAHEN; E M NEUMAYER; M PAULSHOCK; J C WATTS; T R WOOD; E C HERMANN; C E HOFFMANN
Journal:  Science       Date:  1964-05-15       Impact factor: 47.728

  10 in total
  8 in total

Review 1.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

Review 2.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 3.  Amantadine and rimantadine for influenza A in children and the elderly.

Authors:  Márcia G Alves Galvão; Marilene Augusta Rocha Crispino Santos; Antonio J L Alves da Cunha
Journal:  Cochrane Database Syst Rev       Date:  2014-11-21

4.  Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus.

Authors:  S D Sears; M L Clements
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

Review 5.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

6.  In vitro antiviral activity and preliminary clinical trials of a new adamantane compound.

Authors:  A Mathur; A S Beare; S E Reed
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

7.  Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus.

Authors:  Elena A Govorkova; Natalia A Ilyushina; David A Boltz; Alan Douglas; Neziha Yilmaz; Robert G Webster
Journal:  Antimicrob Agents Chemother       Date:  2007-02-12       Impact factor: 5.191

Review 8.  Viral pneumonias.

Authors:  R C Reichman; R Dolin
Journal:  Med Clin North Am       Date:  1980-05       Impact factor: 5.456

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.